<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kolb, Christof</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Dual Chamber ICD Therapy Associated with Fewer Inappropriate Shocks</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">19-20</style></pages><abstract><style  face="normal" font="default" size="100%">This article presents data from an international multicenter study, demonstrating that patients with dual-chamber (DC) implantable cardioverter defibrillators (ICDs) experienced a significantly lower incidence of inappropriate shocks compared with those with single-chamber devices, with no difference in all-cause mortality between the two groups. The Optimal Anti-tachycardia Therapy in ICD Patients Without Pacing Indications study [OPTION; NCT00729703] was designed to test the hypothesis that DC ICD therapy with specific device-based algorithms would reduce the rate of inappropriate shocks without affecting morbidity and mortality by ventricular pacing.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>